Literature DB >> 3544224

Hemodynamic evaluation of the patient with portal hypertension.

J Bosch, R Mastai, D Kravetz, M Navasa, J Rodés.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3544224     DOI： 10.1055/s-2008-1040613

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  18 in total

1.  Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.

Authors:  Hervé Gouya; Sophie Grabar; Olivier Vignaux; Anastasia Saade; Stanislas Pol; Paul Legmann; Philippe Sogni
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

2.  Portal hypertension in acute liver failure.

Authors:  M Navasa; J C Garcia-Pagán; J Bosch; J R Riera; R Bañares; A Mas; M Bruguera; J Rodés
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 3.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

4.  Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial.

Authors:  Hisashi Hidaka; Takahide Nakazawa; Guoqin Wang; Shigehiro Kokubu; Tsutomu Minamino; Juichi Takada; Yoshiaki Tanaka; Yusuke Okuwaki; Masaaki Watanabe; Satoshi Tanabe; Akitaka Shibuya; Wasaburo Koizumi
Journal:  J Gastroenterol       Date:  2011-09-28       Impact factor: 7.527

5.  Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients.

Authors:  Sanjeev Kumar Jha; Ashish Kumar; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2008-12-06       Impact factor: 6.047

6.  Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis.

Authors:  Praveen Sharma; Ashish Kumar; Vimal Mehta; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2007-03       Impact factor: 6.047

7.  Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial.

Authors:  Hisashi Hidaka; Takahide Nakazawa; Akitaka Shibuya; Tsutomu Minamino; Juichi Takada; Yoshiaki Tanaka; Yusuke Okuwaki; Masaaki Watanabe; Wasaburo Koizumi
Journal:  J Gastroenterol       Date:  2011-08-18       Impact factor: 7.527

Review 8.  Pregnancy with portal hypertension.

Authors:  Neelam Aggarwal; Neha Negi; Aakash Aggarwal; Vijay Bodh; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06-23

9.  The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.

Authors:  C Merkel; A Gatta; M Bolognesi; R Padrini; G F Finucci; P Angeli; A Ruol
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

10.  Noninvasive measurement of portal venous blood flow in patients with cirrhosis: effects of physiological and pharmacological stimuli.

Authors:  D Alvarez; R Mastai; A Lennie; G Soifer; D Levi; R Terg
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.